An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy.
about
A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activity.Targeted drugs for systemic therapy of lung cancer with brain metastases.RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo.Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.
P2860
An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
An engineered TIMP2-based and ...... ows potent antitumor efficacy.
@ast
An engineered TIMP2-based and ...... ows potent antitumor efficacy.
@en
type
label
An engineered TIMP2-based and ...... ows potent antitumor efficacy.
@ast
An engineered TIMP2-based and ...... ows potent antitumor efficacy.
@en
prefLabel
An engineered TIMP2-based and ...... ows potent antitumor efficacy.
@ast
An engineered TIMP2-based and ...... ows potent antitumor efficacy.
@en
P2093
P2860
P356
P1433
P1476
An engineered TIMP2-based and ...... ows potent antitumor efficacy.
@en
P2093
Rui-Juan Gao
Sheng-Hua Zhang
Xiu-Jun Liu
Yong-Su Zhen
P2860
P304
26322-26334
P356
10.18632/ONCOTARGET.4709
P407
P577
2015-07-20T00:00:00Z